secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2025-10-02T23:59:59+00:00
Accession:  0001493152-25-016685
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Insight Molecular grants stock options to four executives, amends CSO employment to indefinite term
--------------------------------------------------------------------------------

- Stock options: CEO Riggs 400k shares; CFO James and CSO Schütz 235k each; VP Liu 18k; exercise price $3.33.
- Options vest over 3 years: 1/3 on first anniversary, then monthly over next 2 years, subject to continued service.
- CSO Schütz's employment term amended from fixed 4-year to indefinite until termination; effective Sept 29, 2025.
- Amendment removes references to 'Term Expiration' from severance provisions; all other terms unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315225016685/0001493152-25-016685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315225016685/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-016685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer